Welcome!

News Feed Item

Castlight Health Announces First Quarter 2014 Results

Castlight Health, Inc. (NYSE: CSLT), a pioneer of the Enterprise Healthcare Cloud, today announced results for its first quarter ended March 31, 2014.

“We had a very strong first quarter across our business,” said Giovanni Colella, M.D., co-founder and Chief Executive Officer, Castlight Health. “Demand continues to grow from large enterprises interested in adopting Castlight’s Enterprise Healthcare Cloud platform to gain control over their healthcare spending. During the first quarter we added customers from diverse sectors, including large employers such as Comcast, Freescale Semiconductor and the State of Kansas.”

Colella continued, “Further, we executed 29 customer implementations during the first quarter, including successful launches for a number of Fortune 500 companies. This was nearly three times as many deployments as we had executed in any previous quarter, which gives us great confidence in our ability to meet the increasing demand that we are seeing in the market.”

Financial Performance for the Three Months Ended March 31, 2014

  • Total revenue for the first quarter of 2014 was $8.4 million, an increase of 339% from the first quarter of 2013. Subscription revenue was $7.5 million, an increase of 329% on a year-over-year basis. Professional services revenue was $0.9 million, an increase of 443% compared with the same period last year.
  • Gross margin for the first quarter of 2014 was 21.4%, compared to a gross loss of 70.8% in the first quarter of 2013. Non-GAAP gross margin for the first quarter of 2014 was 23.1% compared to a gross loss of 69.2% in the first quarter of 2013.
  • Operating loss for the first quarter of 2014 was $24.3 million, compared to an operating loss of $11.5 million during the first quarter of 2013. Non-GAAP operating loss for the first quarter of 2014 was $19.3 million, compared to a non-GAAP operating loss of $11.1 million during the first quarter of 2013.
  • Net loss per basic and diluted share was ($0.90) in the first quarter of 2014, compared to a loss of ($1.24) per share in the first quarter of 2013. The first quarter of 2014 non-GAAP loss per share was ($0.72), compared to a loss of ($1.19) per share in the first quarter of 2013. For both GAAP and non-GAAP purposes, the weighted average basic and diluted share count for the first quarter of 2014 was 27.0 million compared to 9.3 million in the first quarter of 2013.
  • Total cash, cash equivalents and marketable securities were $239.7 million at the end of the first quarter of 2014, up from $67.2 million at the end of last quarter. The increase in cash was due to net proceeds of over $185 million from the company’s initial public offering. Cash used in operations for the first quarter of 2014 was $16.1 million, compared to $12.2 million used in operations in the first quarter of 2013.

A reconciliation of GAAP to non-GAAP results has been provided in this press release in the accompanying tables. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures”.

Business Outlook

Q2 2014 Guidance: Revenue for the company’s second fiscal quarter is expected to be in the range of $9.3 million to $9.6 million, an increase of 300% to 313% year over year. Non-GAAP operating loss is expected to be in the range of ($20.0) million to ($20.5) million. Non-GAAP basic and diluted loss per share is expected to be in the range of ($0.22) to ($0.23) based on 90.0 million weighted average basic and diluted common shares outstanding.

Full Year 2014 Guidance: Revenue for the company’s full year 2014 is expected to be in the range of $40.0 million to $41.0 million, an increase of 208% to 216% year over year. Non-GAAP operating loss is expected to be in the range of ($75.5) million to ($76.9) million. Non-GAAP basic and diluted loss per share is expected to be in the range of ($1.01) to ($1.03) based on 75.0 million weighted average basic and diluted common shares outstanding.

For both the second quarter and the full year 2014, non-GAAP estimates exclude the effects of stock-based compensation expense and warrant expense.

Quarterly Conference Call

Castlight Health will host a conference call to discuss its first quarter results today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live audio webcast of the conference call, together with detailed financial information, can be accessed through the company's Investor Relations Web site at http://ir.castlighthealth.com. In addition, an archive of the audiocast can be accessed through the same link. Participants who choose to call in to the conference call can do so by dialing domestically 1-877-407-0789 or internationally at 1-201-689-8562. A replay will be available at 1-877-870-5176 or 1-858-384-5517, passcode 13580401, until midnight (Eastern Time) May 14, 2014.

About Castlight Health

Castlight Health (NYSE: CSLT) is a pioneer of the Enterprise Healthcare Cloud. Founded in 2008, San Francisco-based Castlight makes healthcare data actionable, empowering our enterprise customers to gain control over their healthcare spending and transforming how companies and employees engage in healthcare. With Castlight, employers can implement technology-enabled benefit designs, integrate disparate healthcare applications, and provide meaningful information to employees and their families. More than 100 companies, ranging from medium-sized businesses to Fortune 50 enterprises, have selected Castlight. For more information visit www.castlighthealth.com. Follow us on Twitter and LinkedIn and Like us on Facebook. Source: Castlight Health.

Non-GAAP Financial Measures

To supplement Castlight Health’s financial statements presented in accordance with generally accepted accounting principles (GAAP), we also use and provide investors and others with non-GAAP measures of certain components of financial performance, including non-GAAP gross margin (loss), non-GAAP operating expense, non-GAAP operating loss and non-GAAP net loss per share. These non-GAAP financial measures differ from GAAP financial measures in that they exclude stock-based compensation, expense for a warrant issued to a third party service provider and the associated tax impact of these items, where applicable.

We believe that these non-GAAP financial measures provide useful supplemental information to investors and others, facilitate the analysis of the company’s core operating results and comparison of operating results across reporting periods, and can help enhance overall understanding of the company’s historical financial performance.

We have provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure, except that we have not reconciled our non-GAAP operating loss and net loss per share guidance for the second quarter and full fiscal year of 2014 to comparable GAAP operating loss and net loss per share guidance because we do not provide guidance for share-based compensation expense and warrant expense, which are reconciling items between GAAP and non-GAAP operating loss. The factors that may impact our future share-based compensation expense and warrant expense are out of our control and/or cannot be reasonably predicted, and therefore we are unable to provide such guidance without unreasonable effort.

These non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, measures prepared in accordance with GAAP. Further, these non-GAAP measures may differ from the non-GAAP information used by other companies, including peer companies, and therefore comparability may be limited. Castlight Health encourages investors and others to review the company’s financial information in its entirety and not rely on a single financial measure.

Safe Harbor For Forward-Looking Statements

This press release contains forward-looking statements including, among other things, statements regarding Castlight Health’s first quarter and full year fiscal 2014 revenue projections, and our expectations for future performance of our business, market growth and business conditions. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to: (i) adverse changes in general economic or market conditions; (ii) delays or reductions in information technology spending; (iii) competitive factors, including but not limited to pricing pressures, industry consolidation, entry of new competitors and new applications and marketing initiatives by our competitors; (iv) our ability to manage our growth effectively; (v) our limited operating history, which makes it difficult to predict future results; (vi) the development of the market for enterprise healthcare cloud services; (vii) acceptance of our applications and services by customers; (viii) breaches in our security measures or unauthorized access to our customers’ data; and (ix) the fact that changes in sales may not be immediately reflected in our results due to our subscription model. Further information on risks that could affect Castlight Health’s results and/or cause actual results to vary from expectations is included in the prospectus for our initial public offering, filed with the Securities and Exchange Commission (SEC) on March 14, 2014. Further information on potential risks that could affect actual results will be included in other filings that Castlight Health makes with the SEC from time to time.

The forward-looking statements made in this press release represent Castlight Health’s expectations as of the date of this press release. We assume no obligation to, and do not intend to, update any such forward-looking statements after the date of this press release.

Copyright 2014 Castlight Health, Inc. Castlight Health is the registered trademark of Castlight Health Inc. Other company and product names may be trademarks of the respective companies with which they are associated.

 
CASTLIGHT HEALTH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
 
 
  As of
March 31,   December 31,
  2014   2013  
(unaudited)
Assets
Current assets:
Cash and cash equivalents $ 180,067 $ 25,154
Marketable securities 39,314 42,017
Accounts receivable, net 6,315 5,065
Deferred commissions 2,894 3,648
Prepaid expenses and other current assets   2,683   1,583  
Total current assets 231,273 77,467
 
Property and equipment, net 3,113 2,631
Marketable securities, noncurrent 20,313 -

Restricted cash, noncurrent

101 101
Deferred commissions, noncurrent 1,481 1,821
Other assets   108   1,497  
Total assets $ 256,389 $ 83,517  
 
Liabilities, convertible preferred stock and stockholder's equity (deficit)
 
Current liabilities:
Accounts payable $ 3,318 $ 2,536
Accrued expenses and other current liabilities 4,927 4,998
Accrued compensation 5,394 8,064
Deferred revenue   12,574   6,925  
Total current liabilities 26,213 22,523
 
Deferred revenue, noncurrent 5,585 4,548
Other liabilities, noncurrent   345   373  
Total liabilities 32,143 27,444
Commitments and contingencies
Convertible preferred stock - 180,423
Stockholders' equity (deficit)   224,246   (124,350 )

Total liabilities, convertible preferred stock and stockholders' equity (deficit)

$ 256,389 $ 83,517  
 
 
CASTLIGHT HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(unaudited)
 
 
    Three Months Ended March 31,
  2014       2013  
Revenue:
Subscription $ 7,463 $ 1,739
Professional services   913     168  
Total revenue   8,376     1,907  
Cost of revenue:
Cost of subscription (1) 2,712 1,204
Cost of professional services (1)   3,871     2,053  
Total cost of revenue   6,583     3,257  
Gross profit (loss)   1,793     (1,350 )
Operating expenses:
Sales and marketing (1) 16,560 5,765
Research and development (1) 5,527 2,908
General and administrative (1)   4,010     1,460  
Total operating expenses   26,097     10,133  
Operating loss (24,304 ) (11,483 )
Other income, net   23     50  
Net loss $ (24,281 ) $ (11,433 )
 
Net loss per share, basic and diluted $ (0.90 ) $ (1.24 )
 
Weighted-average shares used to compute basic and diluted net loss per share   26,970     9,255  
 
 
(1) Includes stock-based compensation expense as follows:
 
Three Months Ended March 31,
  2014     2013  
 
Cost of revenue:
Cost of subscription $ 4 $ 1
Cost of professional services 140 29
Sales and marketing 1,174 183
Research and development 421 49
General and administrative 814 116
 
CASTLIGHT HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(unaudited)
 
 
  Three Months Ended March 31,
  2014       2013  
Operating activities:
Net loss $ (24,281 ) $ (11,433 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation 282 100
Stock-based compensation 2,553 378
Amortization of deferred commission 1,376 129
Accretion and amortization of marketable securities 124 228
Expense related to warrant 2,429 -
Changes in operating assets and liabilities:
Accounts receivable (1,250 ) 25
Deferred commissions (282 ) (567 )
Prepaid expenses and other assets (1,081 ) (100 )
Accounts payable 759 (570 )
Accrued expenses and other liabilities (3,376 ) (1,297 )
Deferred revenue   6,686     953  
Net cash used in operating activities   (16,061 )   (12,154 )
 
Investing activities:
Purchase of property and equipment, net (656 ) (710 )
Purchase of marketable securities (35,733 ) (8,098 )
Sales of marketable securities 13,000 5,000
Maturities of marketable securities   5,000     5,000  
Net cash (used in) provided by investing activities   (18,389 )   1,192  
 
Financing activities:
Proceeds from the exercise of stock options 1,522 46

Net proceeds from initial public offering

  187,841     -  
Net cash provided by financing activities   189,363     46  
 
Net increase (decrease) in cash and cash equivalents 154,913 (10,916 )
Cash and cash equivalents at beginning of the period   25,154     42,534  
Cash and cash equivalents at end of the period $ 180,067   $ 31,618  
 
 
CASTLIGHT HEALTH, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(unaudited)
 
  Three Months Ended
March 31,   December 31,   March 31,
  2014     2013     2013  
Gross profit (loss):
GAAP gross profit subscription $ 4,751 $ 2,543 $ 535
GAAP gross margin subscription 63.7 % 55.1 % 30.8 %
Stock-based compensation expense included in cost of revenue subscription   4     3     1  
Non-GAAP gross profit subscription $ 4,755   $ 2,546   $ 536  
Non-GAAP gross margin subscription 63.7 % 55.2 % 30.8 %
 
GAAP gross loss professional services $ (2,958 ) $ (2,790 ) $ (1,885 )
GAAP gross loss percentage professional services (324 )% (540 )% (1,122 )%
Stock-based compensation expense included in cost of revenue professional services   140     35     29  
Non-GAAP gross loss professional services $ (2,818 ) $ (2,755 ) $ (1,856 )
Non-GAAP gross loss percentage professional services

(309

)%

(533

)%

(1,105

)%

 
GAAP gross profit (loss) $ 1,793 $ (247 ) $ (1,350 )
GAAP gross margin (loss percentage) 21.4 % (4.8 )% (70.8 )%
Impact of non-GAAP adjustments   144     38     30  
Non-GAAP gross profit (loss) $ 1,937   $ (209 ) $ (1,320 )
Non-GAAP gross margin (loss percentage) 23.1 % (4.1 )% (69.2 )%
 
 
Operating expense:
GAAP sales and marketing $ 16,560 $ 12,163 $ 5,765
Expense related to warrant (2,429 ) (135 ) -
Stock-based compensation expense included in sales and marketing   (1,174 )   (336 )   (183 )
Non-GAAP sales and marketing $ 12,957   $ 11,692   $ 5,582  
 
GAAP research and development $ 5,527 $ 4,557 $ 2,908
Stock-based compensation expense included in research and development   (421 )   (395 )   (49 )
Non-GAAP research and development $ 5,106   $ 4,162   $ 2,859  
 
GAAP general and administrative $ 4,010 $ 3,035 $ 1,460
Stock-based compensation expense included in general and administrative   (814 )   (285 )   (116 )
Non-GAAP general and administrative $ 3,196   $ 2,750   $ 1,344  
 
GAAP operating expenses $ 26,097 $ 19,755 $ 10,133
Impact of non-GAAP adjustments   (4,838 )   (1,151 )   (348 )
Non-GAAP operating expenses $ 21,259   $ 18,604   $ 9,785  
 
Operating loss:
GAAP operating loss $ (24,304 ) $ (20,002 ) $ (11,483 )
Impact of non-GAAP adjustments   4,982     1,189     378  
Non-GAAP operating loss $ (19,322 ) $ (18,813 ) $ (11,105 )
 
Net loss:
GAAP net loss $ (24,281 ) $ (19,973 ) $ (11,433 )
Total pre-tax impact of non-GAAP adjustments 4,982 1,189 378
Income tax impact of non-GAAP adjustments   -     -     -  
Non-GAAP net loss $ (19,299 ) $ (18,784 ) $ (11,055 )
 
Basic and Diluted net income per share
GAAP $ (0.90 ) $ (1.90 ) $ (1.24 )
Non-GAAP $ (0.72 ) $ (1.79 ) $ (1.19 )
 
Shares used in basic and diluted net loss per share computation   26,970     10,522     9,255  

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., introduced you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He explored applications in several industries and discussed technologies that allow the deployment of advanced visualization solutions to the cloud.
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Agile has finally jumped the technology shark, expanding outside the software world. Enterprises are now increasingly adopting Agile practices across their organizations in order to successfully navigate the disruptive waters that threaten to drown them. In our quest for establishing change as a core competency in our organizations, this business-centric notion of Agile is an essential component of Agile Digital Transformation. In the years since the publication of the Agile Manifesto, the conn...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
In his session at 21st Cloud Expo, Carl J. Levine, Senior Technical Evangelist for NS1, will objectively discuss how DNS is used to solve Digital Transformation challenges in large SaaS applications, CDNs, AdTech platforms, and other demanding use cases. Carl J. Levine is the Senior Technical Evangelist for NS1. A veteran of the Internet Infrastructure space, he has over a decade of experience with startups, networking protocols and Internet infrastructure, combined with the unique ability to it...
Vulnerability management is vital for large companies that need to secure containers across thousands of hosts, but many struggle to understand how exposed they are when they discover a new high security vulnerability. In his session at 21st Cloud Expo, John Morello, CTO of Twistlock, addressed this pressing concern by introducing the concept of the “Vulnerability Risk Tree API,” which brings all the data together in a simple REST endpoint, allowing companies to easily grasp the severity of the ...
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
While some developers care passionately about how data centers and clouds are architected, for most, it is only the end result that matters. To the majority of companies, technology exists to solve a business problem, and only delivers value when it is solving that problem. 2017 brings the mainstream adoption of containers for production workloads. In his session at 21st Cloud Expo, Ben McCormack, VP of Operations at Evernote, discussed how data centers of the future will be managed, how the p...
"NetApp is known as a data management leader but we do a lot more than just data management on-prem with the data centers of our customers. We're also big in the hybrid cloud," explained Wes Talbert, Principal Architect at NetApp, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
The question before companies today is not whether to become intelligent, it’s a question of how and how fast. The key is to adopt and deploy an intelligent application strategy while simultaneously preparing to scale that intelligence. In her session at 21st Cloud Expo, Sangeeta Chakraborty, Chief Customer Officer at Ayasdi, provided a tactical framework to become a truly intelligent enterprise, including how to identify the right applications for AI, how to build a Center of Excellence to oper...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, discussed how from store operations and ...
"Infoblox does DNS, DHCP and IP address management for not only enterprise networks but cloud networks as well. Customers are looking for a single platform that can extend not only in their private enterprise environment but private cloud, public cloud, tracking all the IP space and everything that is going on in that environment," explained Steve Salo, Principal Systems Engineer at Infoblox, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventio...